期刊文献+

粪便钙卫蛋白在新生儿期的临床研究进展 被引量:3

Clinical research advancement of fecal calprotectin during the neonatal period
原文传递
导出
摘要 新生儿胃肠功能异常与生后生长发育落后密切相关,寻找能反映胃肠功能的早期特异性指标有助于指导合理的肠道喂养,预测评价胃肠道疾病的发生.钙卫蛋白是一种主要来源于中性粒细胞的钙-锌结合蛋白质,是急性炎性细胞活化的标志物.有研究表明新生儿期粪便钙卫蛋白呈高水平表达,肠道损伤时粪便钙卫蛋白含量明显升高,并可作为检测胃肠道疾病(如喂养不耐受、新生儿腹泻、坏死性小肠结肠炎等)的发生,评价肠道疾病严重程度的无创性指标.该文就新生儿期粪便钙卫蛋白水平的变化及临床意义作一综述. Neonatal gastrointestinal dysfunction was closely related to postnatal growth retardation.Looking for an early specific indicator to reflect gastrointestinal function was important.Calprotectin was a calciumzinc binding protein mainly in human neutrophil granulocytes,which was the marker of acute inflammatory cell activation.Fecal calprotectin was expressed at high levels during the neonatal period and was significantly higher in the intestinal damage,which could be used as the marker of intestinal illnesses (such as feeding intolerance,neonatal diarrhea,necrotizing enterocolitis).This review will summarize the characteristics of fecal calprotectin in neonates and its clinical significance as a noninvasive marker of intestinal illnesses during the neonatal period.
出处 《国际儿科学杂志》 2013年第6期589-592,共4页 International Journal of Pediatrics
关键词 钙结合蛋白 粪便 新生儿 坏死性小肠结肠炎 Calcium-binding proteins Feces Newborn Necrotizing enterocolitis
  • 相关文献

参考文献26

  • 1Henderson P, Casey A, Lawrence S J, et al. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroentero1,2012,107 ( 6 ) : 941 - 949.
  • 2Bickelhaupt S, Pazahr S, Chuck N, et al. Crohn's disease:small bow- el motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin. Neurogastroenterol Motil, 2013, 25(6) :467-473.
  • 3Cury DB, Mizsputen S J, Versolato C, et al. Serum calprotectin levels correlate with biochemical and histological markers of disease activi- ty in TNBS colitis. Cell Immuno1,2013,282( 1 ) :66-70.
  • 4Terrin G, Passariello A, Manguso F, et al. Serum calprotectin : an an- timicrobial peptide as a new marker for the diagnosis of sepsis in ver- y low birth weight newborns. Clin Dev Immunol, 2011, 2011: 291085.
  • 5Canani RB,Terrin G, Rapacciuolo L, et al. Faecal calprotectin as re- liable non-invasive marker to assess the severity of mucosal inflam- mation in children with inflammatory bowel disease. Dig Liver Dis, 2008,40(7 ) :547-553.
  • 6Lobaton T,Rodrfguez-Moranta F,Lopez A,et al. A new rapid quan- titative test for fecal calprotectin predicts endoscopic activity in ulcer- ative colitis. Inflamm Bowel Dis, 2013,19 ( 5 ) : 1034-1042.
  • 7D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a sur- rogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis,2012,18 ( 12 ) :2218-2224.
  • 8Burri E, Beglinger C. Faecal calprotectin in the diagnosis of inflam- matory bowel disease. Biochem Med ( Zagreb ), 2011,21 ( 3 ) : 245- 253.
  • 9Lashner BA. How useful is fecal calprotectin for the diagnosis of IBD and colorectal cancer? Nat Clin Pract Gastroenterol Hepatol, 2008,5( 1 ) :16-17.
  • 10Kostakis ID, Cholidou KG, Vaiopoulos AG, et al. Fecal calprotectin in pediatric inflammatory bowel disease : a systematic review. Dig Dis Sci,2013,58 (2) :309-319.

同被引文献31

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部